Real Time Touch

new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)

Real Time Touch

Filing Names

Ares Trading S a
Ares Trading S a_20100121

Ares Trading S a patents

Recent patent applications related to Ares Trading S a. Ares Trading S a is listed as an Agent/Assignee. Note: Ares Trading S a may have other listings under different names/spellings. We're not affiliated with Ares Trading S a, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "A" | Ares Trading S a-related inventors

Date Ares Trading S a patents (updated weekly) - BOOKMARK this page
07/27/17Expression vector comprising a polynucleotide encoding a modified glutamine synthetase and a preparing a target protein employing the same
05/25/17Novel ifn beta protein analogs
02/02/17Liquid formulation of a fusion protein comprising tnfr and fc region
01/26/17Liquid formulations of tumor necrosis factor-binding proteins
11/03/16Fgf-18 formulation in xyloglucan gels
10/27/16Medical device connection station
10/20/16Fgf-18 formulation in alginate/collagen hydrogels
09/15/16New medium for high performance mammalian fed-batch cultures
08/25/16Patient care system reporting adherence to treatment regimen
08/11/16Freeze-dried formulations of fgf-18
04/28/16Monoclonal antibody directed against cxcr5
02/25/16Combination of blys inhibition and anti-cd 20 agents for treatment of autoimmune disease
07/09/15Injection device with a capacitive proximity sensor
07/02/15Fused triazole derivatives as gamma secretase modulators
06/25/15Imidazo-oxadiazole and imidazo-thiadiazole derivatives
06/04/15Use of n-acetyl-5-methoxytryptamine or analogues thereof, for promoting the mechanism of implantation of the embryo and related compositions and culture media
05/21/15Pyrimidine pyrazolyl derivatives
05/14/15Pharmaceutical compositions comprising glitazones and nrf2 activators
04/23/15Spiro tetrahydro - benzothiophen derivatives useful for the treatment neurodegenerative diseases
04/09/15Liquid formulations of tumor necrosis factor-binding proteins
01/15/15Combination of blys and/or april inhibition and immunosuppressants for treatment of autoimmune disease
05/01/14Freeze-dried formulations of fgf-18
04/17/14Ifn-beta compositions, preparation methods and uses thereof
03/27/14Genomic markers for prediction of long-term response to 2 years of growth hormone (gh) therapy
07/04/13Pharmaceutical compositions
06/20/13Pharmaceutical compositions
03/22/12Injection device with a capacitive proximity sensor
12/15/11Process for the preparation of glycosylated interferon beta
08/18/11Hand-held electronically controlled injection device for injecting liquid medications
04/28/11Oral formulations of cladribine
01/20/11Cladribine formulations for improved oral and transmucosal delivery
11/25/10Formulations for taci-immunoglobulin fusion proteins
10/14/10Taci-immunoglobulin fusion proteins for treatment of relapsing multiple sclerosis
09/09/10Serum-free cell culture medium for mammalian cells
08/05/10Reeler domain containing protein
07/01/10Use of il-6/il-6 chimera in huntington's disease
06/24/10Hand-held electronically controlled injection device for injecting liquid medications
06/03/10Production of recombinant il-18 binding protein
03/18/10Treatment for multiple myeloma
02/25/10Cystine-knot fold cytokine
01/21/10Treatment of cartilage disorders with fgf-18
12/31/09Oral pharmaceutical composition of anilinopyrimidine, preparation and use thereof
12/17/09Analytical analyzing c-terminus truncation
11/19/09Interleukin-18 mutants, their production and use
08/27/09Tgr3-like protein receptor
08/27/09Cys-rich, cell surface glycoproteins
08/27/09Injection device with a capacitive proximity sensor
08/20/09Method for purifying fsh or a fsh mutant
08/06/09Device for overturning containers
05/28/09Therapy for neurological diseases
05/14/09Serum-free culture medium for the production of recombinant gonadotropins
04/23/09Vwfa and/or ant_ig domain containing proteins
03/19/09Method of treatment using a cytokine able to bind il-18bp to inhibit the activity of a second cytokine
02/26/09Process for the purification of il-18 binding protein
01/21/10Treatment of cartilage disorders with fgf-18

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009


This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. is not affiliated or associated with Ares Trading S a in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Ares Trading S a with additional patents listed. Browse our Agent directory for other possible listings. Page by